Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial

Clinical trial NCT03553004 · UNKNOWN

Trial details

NCT number: NCT03553004
Sponsor: University of Kansas Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2019-01-22
Primary completion: 2023-04-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.